BindingDB logo
myBDB logout
Compile Data Set for Download or QSAR

Found 368 hits Enz. Inhib. hit(s) with Target = 'NS3 serine protease (NS3)'   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kJ/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
NS3 serine protease (NS3)


(Hepatitis C Virus (Virus))
BDBM154573
PNG
(8-(trifluoromethyl)-9H-purin-6-amine (4))
Show SMILES Nc1ncnc2[nH]c(nc12)C(F)(F)F
Show InChI InChI=1S/C6H4F3N5/c7-6(8,9)5-13-2-3(10)11-1-12-4(2)14-5/h1H,(H3,10,11,12,13,14)
PDB

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
Purchase

PC cid
PC sid
UniChem
Article
PubMed
n/an/a>1.00E+5n/an/an/an/a7.5n/a



University of Illinois at Chicago



Assay Description
The fluorogenic substrate used in this study was ubiquitin-AMC (Boston Biochem). All assays were performed in 384-well black plates (Corning) in a to...


ACS Chem Biol 10: 1456-65 (2015)


Article DOI: 10.1021/cb500917m
BindingDB Entry DOI: 10.7270/Q2086426
More data for this
Ligand-Target Pair
NS3 serine protease (NS3)


(Hepatitis C Virus (Virus))
BDBM50007789
PNG
(CHEMBL1173044 | GRL-0667 | N-(2H-1,3-benzodioxol-5...)
Show SMILES C[C@@H](N1CCC(CC1)C(=O)NCc1ccc2OCOc2c1)c1cccc2ccccc12
Show InChI InChI=1S/C26H28N2O3/c1-18(22-8-4-6-20-5-2-3-7-23(20)22)28-13-11-21(12-14-28)26(29)27-16-19-9-10-24-25(15-19)31-17-30-24/h2-10,15,18,21H,11-14,16-17H2,1H3,(H,27,29)/t18-/m1/s1
PDB

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
PDB
UniChem

Similars

Article
PubMed
n/an/a>1.00E+5n/an/an/an/a7.5n/a



University of Illinois at Chicago



Assay Description
The fluorogenic substrate used in this study was ubiquitin-AMC (Boston Biochem). All assays were performed in 384-well black plates (Corning) in a to...


ACS Chem Biol 10: 1456-65 (2015)


Article DOI: 10.1021/cb500917m
BindingDB Entry DOI: 10.7270/Q2086426
More data for this
Ligand-Target Pair
NS3 serine protease (NS3)


(Hepatitis C Virus (Virus))
BDBM204523
PNG
(US9242998, 1)
Show SMILES CNC(=O)c1c(oc2cc(N(C)S(C)(=O)=O)c(cc12)-c1ccc2OCn3c(cc4c(F)cccc34)-c2n1)-c1ccnc(OC)c1
Show InChI InChI=1S/C32H26FN5O6S/c1-34-32(39)29-20-13-19(22-8-9-26-30(36-22)25-14-18-21(33)6-5-7-23(18)38(25)16-43-26)24(37(2)45(4,40)41)15-27(20)44-31(29)17-10-11-35-28(12-17)42-3/h5-15H,16H2,1-4H3,(H,34,39)
PDB

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 14n/an/an/an/an/an/a



Merck Sharp & Dohme Corp.

US Patent


Assay Description
To initiate an assay, replicon cells were plated in the presence of a dilution series of test compound in the absence of G418. Typically, the assays ...


US Patent US9242998 (2016)


BindingDB Entry DOI: 10.7270/Q2SX6C2S
More data for this
Ligand-Target Pair
NS3 serine protease (NS3)


(Hepatitis C Virus (Virus))
BDBM204524
PNG
(US9242998, 2)
Show SMILES CNC(=O)c1c(oc2cc(N(C)S(C)(=O)=O)c(cc12)-c1ccc2OCn3c(cc4c(F)cccc34)-c2n1)C1CC1
Show InChI InChI=1S/C29H25FN4O5S/c1-31-29(35)26-18-11-17(22(33(2)40(3,36)37)13-25(18)39-28(26)15-7-8-15)20-9-10-24-27(32-20)23-12-16-19(30)5-4-6-21(16)34(23)14-38-24/h4-6,9-13,15H,7-8,14H2,1-3H3,(H,31,35)
PDB

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 12n/an/an/an/an/an/a



Merck Sharp & Dohme Corp.

US Patent


Assay Description
To initiate an assay, replicon cells were plated in the presence of a dilution series of test compound in the absence of G418. Typically, the assays ...


US Patent US9242998 (2016)


BindingDB Entry DOI: 10.7270/Q2SX6C2S
More data for this
Ligand-Target Pair
NS3 serine protease (NS3)


(Hepatitis C Virus (Virus))
BDBM204525
PNG
(US9242998, 3)
Show SMILES CNC(=O)c1c(C=C(C)C)oc2cc(N(C)S(C)(=O)=O)c(cc12)-c1ccc2OCn3c(cc4c(F)cccc34)-c2n1
Show InChI InChI=1S/C30H27FN4O5S/c1-16(2)11-27-28(30(36)32-3)19-12-18(23(14-26(19)40-27)34(4)41(5,37)38)21-9-10-25-29(33-21)24-13-17-20(31)7-6-8-22(17)35(24)15-39-25/h6-14H,15H2,1-5H3,(H,32,36)
PDB

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 5.80n/an/an/an/an/an/a



Merck Sharp & Dohme Corp.

US Patent


Assay Description
To initiate an assay, replicon cells were plated in the presence of a dilution series of test compound in the absence of G418. Typically, the assays ...


US Patent US9242998 (2016)


BindingDB Entry DOI: 10.7270/Q2SX6C2S
More data for this
Ligand-Target Pair
NS3 serine protease (NS3)


(Hepatitis C Virus (Virus))
BDBM204526
PNG
(US9242998, 4)
Show SMILES CNC(=O)c1c(oc2cc(N(C)S(C)(=O)=O)c(cc12)-c1ccc2OCn3c(cc4c(F)cccc34)-c2n1)-c1ccc(F)nc1
Show InChI InChI=1S/C31H23F2N5O5S/c1-34-31(39)28-19-11-18(23(37(2)44(3,40)41)13-26(19)43-30(28)16-7-10-27(33)35-14-16)21-8-9-25-29(36-21)24-12-17-20(32)5-4-6-22(17)38(24)15-42-25/h4-14H,15H2,1-3H3,(H,34,39)
PDB

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 6.10n/an/an/an/an/an/a



Merck Sharp & Dohme Corp.

US Patent


Assay Description
To initiate an assay, replicon cells were plated in the presence of a dilution series of test compound in the absence of G418. Typically, the assays ...


US Patent US9242998 (2016)


BindingDB Entry DOI: 10.7270/Q2SX6C2S
More data for this
Ligand-Target Pair
NS3 serine protease (NS3)


(Hepatitis C Virus (Virus))
BDBM204527
PNG
(US9242998, 5)
Show SMILES CNC(=O)c1c(oc2cc(N(C)S(C)(=O)=O)c(cc12)-c1ccc2OCn3c(cc4c(F)cccc34)-c2n1)-c1cnn(C)c1
Show InChI InChI=1S/C30H25FN6O5S/c1-32-30(38)27-19-10-18(23(36(3)43(4,39)40)12-26(19)42-29(27)16-13-33-35(2)14-16)21-8-9-25-28(34-21)24-11-17-20(31)6-5-7-22(17)37(24)15-41-25/h5-14H,15H2,1-4H3,(H,32,38)
PDB

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 7.5n/an/an/an/an/an/a



Merck Sharp & Dohme Corp.

US Patent


Assay Description
To initiate an assay, replicon cells were plated in the presence of a dilution series of test compound in the absence of G418. Typically, the assays ...


US Patent US9242998 (2016)


BindingDB Entry DOI: 10.7270/Q2SX6C2S
More data for this
Ligand-Target Pair
NS3 serine protease (NS3)


(Hepatitis C Virus (Virus))
BDBM204528
PNG
(US9242998, 6)
Show SMILES CCOc1ccc(cn1)-c1oc2cc(N(C)S(C)(=O)=O)c(cc2c1C(=O)NC)-c1ccc2OCn3c(cc4c(F)cccc34)-c2n1
Show InChI InChI=1S/C33H28FN5O6S/c1-5-43-29-12-9-18(16-36-29)32-30(33(40)35-2)21-13-20(25(15-28(21)45-32)38(3)46(4,41)42)23-10-11-27-31(37-23)26-14-19-22(34)7-6-8-24(19)39(26)17-44-27/h6-16H,5,17H2,1-4H3,(H,35,40)
PDB

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 12n/an/an/an/an/an/a



Merck Sharp & Dohme Corp.

US Patent


Assay Description
To initiate an assay, replicon cells were plated in the presence of a dilution series of test compound in the absence of G418. Typically, the assays ...


US Patent US9242998 (2016)


BindingDB Entry DOI: 10.7270/Q2SX6C2S
More data for this
Ligand-Target Pair
NS3 serine protease (NS3)


(Hepatitis C Virus (Virus))
BDBM204529
PNG
(US9242998, 7)
Show SMILES CNC(=O)c1c(oc2cc(N(C)S(C)(=O)=O)c(cc12)-c1ccc2OCn3c(cc4c(F)cccc34)-c2n1)-c1ccc(C)nc1
Show InChI InChI=1S/C32H26FN5O5S/c1-17-8-9-18(15-35-17)31-29(32(39)34-2)21-12-20(25(14-28(21)43-31)37(3)44(4,40)41)23-10-11-27-30(36-23)26-13-19-22(33)6-5-7-24(19)38(26)16-42-27/h5-15H,16H2,1-4H3,(H,34,39)
PDB

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 13n/an/an/an/an/an/a



Merck Sharp & Dohme Corp.

US Patent


Assay Description
To initiate an assay, replicon cells were plated in the presence of a dilution series of test compound in the absence of G418. Typically, the assays ...


US Patent US9242998 (2016)


BindingDB Entry DOI: 10.7270/Q2SX6C2S
More data for this
Ligand-Target Pair
NS3 serine protease (NS3)


(Hepatitis C Virus (Virus))
BDBM204530
PNG
(US9242998, 8)
Show SMILES CNC(=O)c1c(oc2cc(N(C)S(C)(=O)=O)c(cc12)-c1ccc2OCn3c(cc4c(F)cccc34)-c2n1)-c1ccc(cc1)C(F)(F)F
Show InChI InChI=1S/C33H24F4N4O5S/c1-38-32(42)29-21-13-20(23-11-12-27-30(39-23)26-14-19-22(34)5-4-6-24(19)41(26)16-45-27)25(40(2)47(3,43)44)15-28(21)46-31(29)17-7-9-18(10-8-17)33(35,36)37/h4-15H,16H2,1-3H3,(H,38,42)
PDB

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 4.5n/an/an/an/an/an/a



Merck Sharp & Dohme Corp.

US Patent


Assay Description
To initiate an assay, replicon cells were plated in the presence of a dilution series of test compound in the absence of G418. Typically, the assays ...


US Patent US9242998 (2016)


BindingDB Entry DOI: 10.7270/Q2SX6C2S
More data for this
Ligand-Target Pair
NS3 serine protease (NS3)


(Hepatitis C Virus (Virus))
BDBM204531
PNG
(US9242998, 9)
Show SMILES CNC(=O)c1c(oc2cc(N(C)S(C)(=O)=O)c(cc12)-c1ccc2OCn3c(cc4c(F)cccc34)-c2n1)-c1ccc(nc1)C(F)F
Show InChI InChI=1S/C32H24F3N5O5S/c1-36-32(41)28-19-11-18(21-9-10-26-29(38-21)25-12-17-20(33)5-4-6-23(17)40(25)15-44-26)24(39(2)46(3,42)43)13-27(19)45-30(28)16-7-8-22(31(34)35)37-14-16/h4-14,31H,15H2,1-3H3,(H,36,41)
PDB

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 3.40n/an/an/an/an/an/a



Merck Sharp & Dohme Corp.

US Patent


Assay Description
To initiate an assay, replicon cells were plated in the presence of a dilution series of test compound in the absence of G418. Typically, the assays ...


US Patent US9242998 (2016)


BindingDB Entry DOI: 10.7270/Q2SX6C2S
More data for this
Ligand-Target Pair
NS3 serine protease (NS3)


(Hepatitis C Virus (Virus))
BDBM204532
PNG
(US9242998, 10)
Show SMILES CNC(=O)c1c(oc2cc(N(C)S(C)(=O)=O)c(cc12)-c1ccc2OCn3c(cc4c(F)cccc34)-c2n1)-c1ccc(OC(C)C)nc1
Show InChI InChI=1S/C34H30FN5O6S/c1-18(2)45-30-12-9-19(16-37-30)33-31(34(41)36-3)22-13-21(26(15-29(22)46-33)39(4)47(5,42)43)24-10-11-28-32(38-24)27-14-20-23(35)7-6-8-25(20)40(27)17-44-28/h6-16,18H,17H2,1-5H3,(H,36,41)
PDB

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 13n/an/an/an/an/an/a



Merck Sharp & Dohme Corp.

US Patent


Assay Description
To initiate an assay, replicon cells were plated in the presence of a dilution series of test compound in the absence of G418. Typically, the assays ...


US Patent US9242998 (2016)


BindingDB Entry DOI: 10.7270/Q2SX6C2S
More data for this
Ligand-Target Pair
NS3 serine protease (NS3)


(Hepatitis C Virus (Virus))
BDBM204533
PNG
(US9242998, 11)
Show SMILES CNC(=O)c1c(oc2cc(N(C)S(C)(=O)=O)c(cc12)-c1ccc2OCn3c(cc4c(F)cccc34)-c2n1)-c1ccc(OC)nc1
Show InChI InChI=1S/C32H26FN5O6S/c1-34-32(39)29-20-12-19(22-9-10-26-30(36-22)25-13-18-21(33)6-5-7-23(18)38(25)16-43-26)24(37(2)45(4,40)41)14-27(20)44-31(29)17-8-11-28(42-3)35-15-17/h5-15H,16H2,1-4H3,(H,34,39)
PDB

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 8.40n/an/an/an/an/an/a



Merck Sharp & Dohme Corp.

US Patent


Assay Description
To initiate an assay, replicon cells were plated in the presence of a dilution series of test compound in the absence of G418. Typically, the assays ...


US Patent US9242998 (2016)


BindingDB Entry DOI: 10.7270/Q2SX6C2S
More data for this
Ligand-Target Pair
NS3 serine protease (NS3)


(Hepatitis C Virus (Virus))
BDBM204534
PNG
(US9242998, 12)
Show SMILES CNC(=O)c1c(oc2cc(N(C)S(C)(=O)=O)c(cc12)-c1ccc2OCn3c(cc4c(F)cccc34)-c2n1)-c1ccc(OCC(F)(F)F)nc1
Show InChI InChI=1S/C33H25F4N5O6S/c1-38-32(43)29-20-11-19(22-8-9-26-30(40-22)25-12-18-21(34)5-4-6-23(18)42(25)16-47-26)24(41(2)49(3,44)45)13-27(20)48-31(29)17-7-10-28(39-14-17)46-15-33(35,36)37/h4-14H,15-16H2,1-3H3,(H,38,43)
PDB

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 1.80n/an/an/an/an/an/a



Merck Sharp & Dohme Corp.

US Patent


Assay Description
To initiate an assay, replicon cells were plated in the presence of a dilution series of test compound in the absence of G418. Typically, the assays ...


US Patent US9242998 (2016)


BindingDB Entry DOI: 10.7270/Q2SX6C2S
More data for this
Ligand-Target Pair
NS3 serine protease (NS3)


(Hepatitis C Virus (Virus))
BDBM204535
PNG
(US9242998, 13)
Show SMILES CNC(=O)c1c(oc2cc(N(C)S(C)(=O)=O)c(cc12)-c1ccc2OCn3c(cc4c(F)cccc34)-c2n1)-c1cnc(OC)nc1
Show InChI InChI=1S/C31H25FN6O6S/c1-33-30(39)27-19-10-18(21-8-9-25-28(36-21)24-11-17-20(32)6-5-7-22(17)38(24)15-43-25)23(37(2)45(4,40)41)12-26(19)44-29(27)16-13-34-31(42-3)35-14-16/h5-14H,15H2,1-4H3,(H,33,39)
PDB

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 9.40n/an/an/an/an/an/a



Merck Sharp & Dohme Corp.

US Patent


Assay Description
To initiate an assay, replicon cells were plated in the presence of a dilution series of test compound in the absence of G418. Typically, the assays ...


US Patent US9242998 (2016)


BindingDB Entry DOI: 10.7270/Q2SX6C2S
More data for this
Ligand-Target Pair
NS3 serine protease (NS3)


(Hepatitis C Virus (Virus))
BDBM204536
PNG
(US9242998, 14)
Show SMILES CCn1cc(cn1)-c1oc2cc(N(C)S(C)(=O)=O)c(cc2c1C(=O)NC)-c1ccc2OCn3c(cc4c(F)cccc34)-c2n1
Show InChI InChI=1S/C31H27FN6O5S/c1-5-37-15-17(14-34-37)30-28(31(39)33-2)20-11-19(24(13-27(20)43-30)36(3)44(4,40)41)22-9-10-26-29(35-22)25-12-18-21(32)7-6-8-23(18)38(25)16-42-26/h6-15H,5,16H2,1-4H3,(H,33,39)
PDB

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 18n/an/an/an/an/an/a



Merck Sharp & Dohme Corp.

US Patent


Assay Description
To initiate an assay, replicon cells were plated in the presence of a dilution series of test compound in the absence of G418. Typically, the assays ...


US Patent US9242998 (2016)


BindingDB Entry DOI: 10.7270/Q2SX6C2S
More data for this
Ligand-Target Pair
NS3 serine protease (NS3)


(Hepatitis C Virus (Virus))
BDBM204537
PNG
(US9242998, 15)
Show SMILES CNC(=O)c1c(oc2cc(N(C)S(C)(=O)=O)c(cc12)-c1ccc2OCn3c(cc4c(F)cccc34)-c2n1)-c1cccnc1OC
Show InChI InChI=1S/C32H26FN5O6S/c1-34-31(39)28-20-13-19(22-10-11-26-29(36-22)25-14-18-21(33)8-5-9-23(18)38(25)16-43-26)24(37(2)45(4,40)41)15-27(20)44-30(28)17-7-6-12-35-32(17)42-3/h5-15H,16H2,1-4H3,(H,34,39)
PDB

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 34n/an/an/an/an/an/a



Merck Sharp & Dohme Corp.

US Patent


Assay Description
To initiate an assay, replicon cells were plated in the presence of a dilution series of test compound in the absence of G418. Typically, the assays ...


US Patent US9242998 (2016)


BindingDB Entry DOI: 10.7270/Q2SX6C2S
More data for this
Ligand-Target Pair
NS3 serine protease (NS3)


(Hepatitis C Virus (Virus))
BDBM204538
PNG
(US9242998, 16)
Show SMILES CNC(=O)c1c(oc2cc(N(C)S(C)(=O)=O)c(cc12)-c1ccc2OCn3c(cc4c(F)cccc34)-c2n1)-c1cn(C)nc1C
Show InChI InChI=1S/C31H27FN6O5S/c1-16-20(14-36(3)35-16)30-28(31(39)33-2)19-11-18(24(13-27(19)43-30)37(4)44(5,40)41)22-9-10-26-29(34-22)25-12-17-21(32)7-6-8-23(17)38(25)15-42-26/h6-14H,15H2,1-5H3,(H,33,39)
PDB

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 8.5n/an/an/an/an/an/a



Merck Sharp & Dohme Corp.

US Patent


Assay Description
To initiate an assay, replicon cells were plated in the presence of a dilution series of test compound in the absence of G418. Typically, the assays ...


US Patent US9242998 (2016)


BindingDB Entry DOI: 10.7270/Q2SX6C2S
More data for this
Ligand-Target Pair
NS3 serine protease (NS3)


(Hepatitis C Virus (Virus))
BDBM204539
PNG
(US9242998, 17)
Show SMILES CNC(=O)c1c(oc2cc(N(C)S(C)(=O)=O)c(cc12)-c1ccc2OCn3c(cc4c(F)cccc34)-c2n1)-c1cccnc1O
Show InChI InChI=1S/C31H24FN5O6S/c1-33-31(39)27-19-12-18(23(36(2)44(3,40)41)14-26(19)43-29(27)16-6-5-11-34-30(16)38)21-9-10-25-28(35-21)24-13-17-20(32)7-4-8-22(17)37(24)15-42-25/h4-14H,15H2,1-3H3,(H,33,39)(H,34,38)
PDB

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 393n/an/an/an/an/an/a



Merck Sharp & Dohme Corp.

US Patent


Assay Description
To initiate an assay, replicon cells were plated in the presence of a dilution series of test compound in the absence of G418. Typically, the assays ...


US Patent US9242998 (2016)


BindingDB Entry DOI: 10.7270/Q2SX6C2S
More data for this
Ligand-Target Pair
NS3 serine protease (NS3)


(Hepatitis C Virus (Virus))
BDBM204540
PNG
(US9242998, 18)
Show SMILES CNC(=O)c1c(oc2cc(N(C)S(C)(=O)=O)c(cc12)-c1ccc2OCn3c(cc4c(F)cccc34)-c2n1)-c1ccn(C)c(=O)c1
Show InChI InChI=1S/C32H26FN5O6S/c1-34-32(40)29-20-13-19(22-8-9-26-30(35-22)25-14-18-21(33)6-5-7-23(18)38(25)16-43-26)24(37(3)45(4,41)42)15-27(20)44-31(29)17-10-11-36(2)28(39)12-17/h5-15H,16H2,1-4H3,(H,34,40)
PDB

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 29n/an/an/an/an/an/a



Merck Sharp & Dohme Corp.

US Patent


Assay Description
To initiate an assay, replicon cells were plated in the presence of a dilution series of test compound in the absence of G418. Typically, the assays ...


US Patent US9242998 (2016)


BindingDB Entry DOI: 10.7270/Q2SX6C2S
More data for this
Ligand-Target Pair
NS3 serine protease (NS3)


(Hepatitis C Virus (Virus))
BDBM204581
PNG
(US9242998, 19)
Show SMILES CNC(=O)c1c(oc2cc(N(C)S(C)(=O)=O)c(cc12)-c1ccc2OCn3c(nc4cccc(F)c34)-c2n1)-c1ccc(OC)nc1
Show InChI InChI=1S/C31H25FN6O6S/c1-33-31(39)26-18-12-17(20-9-10-23-27(35-20)30-36-21-7-5-6-19(32)28(21)38(30)15-43-23)22(37(2)45(4,40)41)13-24(18)44-29(26)16-8-11-25(42-3)34-14-16/h5-14H,15H2,1-4H3,(H,33,39)
PDB

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 13n/an/an/an/an/an/a



Merck Sharp & Dohme Corp.

US Patent


Assay Description
To initiate an assay, replicon cells were plated in the presence of a dilution series of test compound in the absence of G418. Typically, the assays ...


US Patent US9242998 (2016)


BindingDB Entry DOI: 10.7270/Q2SX6C2S
More data for this
Ligand-Target Pair
NS3 serine protease (NS3)


(Hepatitis C Virus (Virus))
BDBM204541
PNG
(US9242998, 20)
Show SMILES CNC(=O)c1c(oc2cc(N(C)S(C)(=O)=O)c(cc12)-c1ccc2OCn3c(nc4c(F)cccc34)-c2n1)-c1ccc(OC)nc1
Show InChI InChI=1S/C31H25FN6O6S/c1-33-31(39)26-18-12-17(20-9-10-23-28(35-20)30-36-27-19(32)6-5-7-21(27)38(30)15-43-23)22(37(2)45(4,40)41)13-24(18)44-29(26)16-8-11-25(42-3)34-14-16/h5-14H,15H2,1-4H3,(H,33,39)
PDB

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 2.5n/an/an/an/an/an/a



Merck Sharp & Dohme Corp.

US Patent


Assay Description
To initiate an assay, replicon cells were plated in the presence of a dilution series of test compound in the absence of G418. Typically, the assays ...


US Patent US9242998 (2016)


BindingDB Entry DOI: 10.7270/Q2SX6C2S
More data for this
Ligand-Target Pair
NS3 serine protease (NS3)


(Hepatitis C Virus (Virus))
BDBM204542
PNG
(US9242998, 21)
Show SMILES CNC(=O)c1c(oc2cc(N(C)S(C)(=O)=O)c(cc12)-c1ccc2OC(CO)n3c(cc4c(F)cccc34)-c2n1)-c1ccc(OC)nc1
Show InChI InChI=1S/C33H28FN5O7S/c1-35-33(41)30-20-12-19(24(38(2)47(4,42)43)14-27(20)46-32(30)17-8-11-28(44-3)36-15-17)22-9-10-26-31(37-22)25-13-18-21(34)6-5-7-23(18)39(25)29(16-40)45-26/h5-15,29,40H,16H2,1-4H3,(H,35,41)
PDB

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 2.80n/an/an/an/an/an/a



Merck Sharp & Dohme Corp.

US Patent


Assay Description
To initiate an assay, replicon cells were plated in the presence of a dilution series of test compound in the absence of G418. Typically, the assays ...


US Patent US9242998 (2016)


BindingDB Entry DOI: 10.7270/Q2SX6C2S
More data for this
Ligand-Target Pair
NS3 serine protease (NS3)


(Hepatitis C Virus (Virus))
BDBM204543
PNG
(US9242998, 22)
Show SMILES CNC(=O)c1c(oc2cc(N(C)S(C)(=O)=O)c(cc12)-c1ccc2OC(CO)n3c(cc4c(F)cccc34)-c2n1)-c1ccc(nc1)C(F)F
Show InChI InChI=1S/C33H26F3N5O6S/c1-37-33(43)29-19-11-18(24(40(2)48(3,44)45)13-27(19)47-31(29)16-7-8-22(32(35)36)38-14-16)21-9-10-26-30(39-21)25-12-17-20(34)5-4-6-23(17)41(25)28(15-42)46-26/h4-14,28,32,42H,15H2,1-3H3,(H,37,43)
PDB

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 2.5n/an/an/an/an/an/a



Merck Sharp & Dohme Corp.

US Patent


Assay Description
To initiate an assay, replicon cells were plated in the presence of a dilution series of test compound in the absence of G418. Typically, the assays ...


US Patent US9242998 (2016)


BindingDB Entry DOI: 10.7270/Q2SX6C2S
More data for this
Ligand-Target Pair
NS3 serine protease (NS3)


(Hepatitis C Virus (Virus))
BDBM204544
PNG
(US9242998, 23)
Show SMILES CNC(=O)c1c(oc2cc(N(C)S(C)(=O)=O)c(cc12)-c1ccc2OC(CO)n3c(cc4c(F)cccc34)-c2n1)-c1ccc(OC(F)F)nc1
Show InChI InChI=1S/C33H26F3N5O7S/c1-37-32(43)29-19-11-18(21-8-9-25-30(39-21)24-12-17-20(34)5-4-6-22(17)41(24)28(15-42)46-25)23(40(2)49(3,44)45)13-26(19)47-31(29)16-7-10-27(38-14-16)48-33(35)36/h4-14,28,33,42H,15H2,1-3H3,(H,37,43)
PDB

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 2.90n/an/an/an/an/an/a



Merck Sharp & Dohme Corp.

US Patent


Assay Description
To initiate an assay, replicon cells were plated in the presence of a dilution series of test compound in the absence of G418. Typically, the assays ...


US Patent US9242998 (2016)


BindingDB Entry DOI: 10.7270/Q2SX6C2S
More data for this
Ligand-Target Pair
NS3 serine protease (NS3)


(Hepatitis C Virus (Virus))
BDBM204545
PNG
(US9242998, 24)
Show SMILES CNC(=O)c1c(oc2cc(N(C)S(C)(=O)=O)c(cc12)-c1ccc2OC(CO)n3c(cc4c(F)cccc34)-c2n1)-c1ccc(OCC(F)(F)F)nc1
Show InChI InChI=1S/C34H27F4N5O7S/c1-39-33(45)30-20-11-19(22-8-9-26-31(41-22)25-12-18-21(35)5-4-6-23(18)43(25)29(15-44)49-26)24(42(2)51(3,46)47)13-27(20)50-32(30)17-7-10-28(40-14-17)48-16-34(36,37)38/h4-14,29,44H,15-16H2,1-3H3,(H,39,45)
PDB

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 1.40n/an/an/an/an/an/a



Merck Sharp & Dohme Corp.

US Patent


Assay Description
To initiate an assay, replicon cells were plated in the presence of a dilution series of test compound in the absence of G418. Typically, the assays ...


US Patent US9242998 (2016)


BindingDB Entry DOI: 10.7270/Q2SX6C2S
More data for this
Ligand-Target Pair
NS3 serine protease (NS3)


(Hepatitis C Virus (Virus))
BDBM204580
PNG
(US9242998, 25)
Show SMILES CNC(=O)c1c(oc2cc(N(C)S(C)(=O)=O)c(cc12)-c1ccc2OCn3c(cc4c(F)cccc34)-c2n1)-c1ccc(OC(F)F)nc1
Show InChI InChI=1S/C32H24F3N5O6S/c1-36-31(41)28-19-11-18(21-8-9-25-29(38-21)24-12-17-20(33)5-4-6-22(17)40(24)15-44-25)23(39(2)47(3,42)43)13-26(19)45-30(28)16-7-10-27(37-14-16)46-32(34)35/h4-14,32H,15H2,1-3H3,(H,36,41)
PDB

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 5n/an/an/an/an/an/a



Merck Sharp & Dohme Corp.

US Patent


Assay Description
To initiate an assay, replicon cells were plated in the presence of a dilution series of test compound in the absence of G418. Typically, the assays ...


US Patent US9242998 (2016)


BindingDB Entry DOI: 10.7270/Q2SX6C2S
More data for this
Ligand-Target Pair
NS3 serine protease (NS3)


(Hepatitis C Virus (Virus))
BDBM204546
PNG
(US9242998, 26)
Show SMILES CNC(=O)c1c(oc2cc(N(C)S(C)(=O)=O)c(cc12)-c1ccc2OCn3c(cc4c(F)cccc34)-c2n1)-c1ccc(=O)n(c1)C(F)F
Show InChI InChI=1S/C32H24F3N5O6S/c1-36-31(42)28-19-11-18(21-8-9-25-29(37-21)24-12-17-20(33)5-4-6-22(17)40(24)15-45-25)23(38(2)47(3,43)44)13-26(19)46-30(28)16-7-10-27(41)39(14-16)32(34)35/h4-14,32H,15H2,1-3H3,(H,36,42)
PDB

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 108n/an/an/an/an/an/a



Merck Sharp & Dohme Corp.

US Patent


Assay Description
To initiate an assay, replicon cells were plated in the presence of a dilution series of test compound in the absence of G418. Typically, the assays ...


US Patent US9242998 (2016)


BindingDB Entry DOI: 10.7270/Q2SX6C2S
More data for this
Ligand-Target Pair
NS3 serine protease (NS3)


(Hepatitis C Virus (Virus))
BDBM204547
PNG
(US9242998, 27)
Show SMILES CNC(=O)c1c(oc2cc(N(C)S(C)(=O)=O)c(cc12)-c1ccc2OCn3c(cc4c(F)cccc34)-c2n1)-c1ccc(Oc2ccc(F)cc2)nc1
Show InChI InChI=1S/C37H27F2N5O6S/c1-40-37(45)34-25-15-24(27-12-13-31-35(42-27)30-16-23-26(39)5-4-6-28(23)44(30)19-48-31)29(43(2)51(3,46)47)17-32(25)50-36(34)20-7-14-33(41-18-20)49-22-10-8-21(38)9-11-22/h4-18H,19H2,1-3H3,(H,40,45)
PDB

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 34n/an/an/an/an/an/a



Merck Sharp & Dohme Corp.

US Patent


Assay Description
To initiate an assay, replicon cells were plated in the presence of a dilution series of test compound in the absence of G418. Typically, the assays ...


US Patent US9242998 (2016)


BindingDB Entry DOI: 10.7270/Q2SX6C2S
More data for this
Ligand-Target Pair
NS3 serine protease (NS3)


(Hepatitis C Virus (Virus))
BDBM204548
PNG
(US9242998, 28)
Show SMILES CNC(=O)c1c(oc2cc(N(C)S(C)(=O)=O)c(cc12)-c1ccc2OCn3c(cc4c(F)cccc34)-c2n1)-c1ccc(cc1)C(F)F
Show InChI InChI=1S/C33H25F3N4O5S/c1-37-33(41)29-21-13-20(23-11-12-27-30(38-23)26-14-19-22(34)5-4-6-24(19)40(26)16-44-27)25(39(2)46(3,42)43)15-28(21)45-31(29)17-7-9-18(10-8-17)32(35)36/h4-15,32H,16H2,1-3H3,(H,37,41)
PDB

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 6.90n/an/an/an/an/an/a



Merck Sharp & Dohme Corp.

US Patent


Assay Description
To initiate an assay, replicon cells were plated in the presence of a dilution series of test compound in the absence of G418. Typically, the assays ...


US Patent US9242998 (2016)


BindingDB Entry DOI: 10.7270/Q2SX6C2S
More data for this
Ligand-Target Pair
NS3 serine protease (NS3)


(Hepatitis C Virus (Virus))
BDBM204549
PNG
(US9242998, 29)
Show SMILES CNC(=O)c1c(oc2cc(N(C)S(C)(=O)=O)c(cc12)-c1ccc2OCn3c(cc4c(F)cccc34)-c2n1)-c1ccc(cc1)C#N
Show InChI InChI=1S/C33H24FN5O5S/c1-36-33(40)30-22-13-21(24-11-12-28-31(37-24)27-14-20-23(34)5-4-6-25(20)39(27)17-43-28)26(38(2)45(3,41)42)15-29(22)44-32(30)19-9-7-18(16-35)8-10-19/h4-15H,17H2,1-3H3,(H,36,40)
PDB

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 25n/an/an/an/an/an/a



Merck Sharp & Dohme Corp.

US Patent


Assay Description
To initiate an assay, replicon cells were plated in the presence of a dilution series of test compound in the absence of G418. Typically, the assays ...


US Patent US9242998 (2016)


BindingDB Entry DOI: 10.7270/Q2SX6C2S
More data for this
Ligand-Target Pair
NS3 serine protease (NS3)


(Hepatitis C Virus (Virus))
BDBM204550
PNG
(US9242998, 30)
Show SMILES CNC(=O)c1c(oc2cc(N(C)S(C)(=O)=O)c(cc12)-c1ccc2OCn3c(cc4c(F)cccc34)-c2n1)-c1ccc(F)cn1
Show InChI InChI=1S/C31H23F2N5O5S/c1-34-31(39)28-19-11-18(24(37(2)44(3,40)41)13-27(19)43-30(28)22-8-7-16(32)14-35-22)21-9-10-26-29(36-21)25-12-17-20(33)5-4-6-23(17)38(25)15-42-26/h4-14H,15H2,1-3H3,(H,34,39)
PDB

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 25n/an/an/an/an/an/a



Merck Sharp & Dohme Corp.

US Patent


Assay Description
To initiate an assay, replicon cells were plated in the presence of a dilution series of test compound in the absence of G418. Typically, the assays ...


US Patent US9242998 (2016)


BindingDB Entry DOI: 10.7270/Q2SX6C2S
More data for this
Ligand-Target Pair
NS3 serine protease (NS3)


(Hepatitis C Virus (Virus))
BDBM204551
PNG
(US9242998, 31)
Show SMILES CNC(=O)c1c(oc2cc(N(C)S(C)(=O)=O)c(cc12)-c1ccc2OCn3c(cc4c(F)cccc34)-c2n1)-c1ccc(cn1)C(F)(F)F
Show InChI InChI=1S/C32H23F4N5O5S/c1-37-31(42)28-19-11-18(21-9-10-26-29(39-21)25-12-17-20(33)5-4-6-23(17)41(25)15-45-26)24(40(2)47(3,43)44)13-27(19)46-30(28)22-8-7-16(14-38-22)32(34,35)36/h4-14H,15H2,1-3H3,(H,37,42)
PDB

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 3.90n/an/an/an/an/an/a



Merck Sharp & Dohme Corp.

US Patent


Assay Description
To initiate an assay, replicon cells were plated in the presence of a dilution series of test compound in the absence of G418. Typically, the assays ...


US Patent US9242998 (2016)


BindingDB Entry DOI: 10.7270/Q2SX6C2S
More data for this
Ligand-Target Pair
NS3 serine protease (NS3)


(Hepatitis C Virus (Virus))
BDBM204552
PNG
(US9242998, 32)
Show SMILES CNC(=O)c1c(oc2cc(N(C)S(C)(=O)=O)c(cc12)-c1ccc2OCn3c(cc4c(F)cccc34)-c2n1)C1=CCSCC1
Show InChI InChI=1S/C31H27FN4O5S2/c1-33-31(37)28-20-13-19(24(35(2)43(3,38)39)15-27(20)41-30(28)17-9-11-42-12-10-17)22-7-8-26-29(34-22)25-14-18-21(32)5-4-6-23(18)36(25)16-40-26/h4-9,13-15H,10-12,16H2,1-3H3,(H,33,37)
PDB

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 14n/an/an/an/an/an/a



Merck Sharp & Dohme Corp.

US Patent


Assay Description
To initiate an assay, replicon cells were plated in the presence of a dilution series of test compound in the absence of G418. Typically, the assays ...


US Patent US9242998 (2016)


BindingDB Entry DOI: 10.7270/Q2SX6C2S
More data for this
Ligand-Target Pair
NS3 serine protease (NS3)


(Hepatitis C Virus (Virus))
BDBM204553
PNG
(US9242998, 33)
Show SMILES CNC(=O)c1c(oc2cc(N(C)S(C)(=O)=O)c(cc12)-c1ccc2OCn3c(cc4c(F)cccc34)-c2n1)-c1ccc(OC(F)(F)F)cc1
Show InChI InChI=1S/C33H24F4N4O6S/c1-38-32(42)29-21-13-20(23-11-12-27-30(39-23)26-14-19-22(34)5-4-6-24(19)41(26)16-45-27)25(40(2)48(3,43)44)15-28(21)46-31(29)17-7-9-18(10-8-17)47-33(35,36)37/h4-15H,16H2,1-3H3,(H,38,42)
PDB

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 2.5n/an/an/an/an/an/a



Merck Sharp & Dohme Corp.

US Patent


Assay Description
To initiate an assay, replicon cells were plated in the presence of a dilution series of test compound in the absence of G418. Typically, the assays ...


US Patent US9242998 (2016)


BindingDB Entry DOI: 10.7270/Q2SX6C2S
More data for this
Ligand-Target Pair
NS3 serine protease (NS3)


(Hepatitis C Virus (Virus))
BDBM204554
PNG
(US9242998, 34)
Show SMILES CNC(=O)c1c(oc2cc(N(C)S(C)(=O)=O)c(cc12)-c1ccc2OCn3c(cc4c(F)cccc34)-c2n1)-c1cnn(c1)C(C)C
Show InChI InChI=1S/C32H29FN6O5S/c1-17(2)39-15-18(14-35-39)31-29(32(40)34-3)21-11-20(25(13-28(21)44-31)37(4)45(5,41)42)23-9-10-27-30(36-23)26-12-19-22(33)7-6-8-24(19)38(26)16-43-27/h6-15,17H,16H2,1-5H3,(H,34,40)
PDB

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 14n/an/an/an/an/an/a



Merck Sharp & Dohme Corp.

US Patent


Assay Description
To initiate an assay, replicon cells were plated in the presence of a dilution series of test compound in the absence of G418. Typically, the assays ...


US Patent US9242998 (2016)


BindingDB Entry DOI: 10.7270/Q2SX6C2S
More data for this
Ligand-Target Pair
NS3 serine protease (NS3)


(Hepatitis C Virus (Virus))
BDBM204555
PNG
(US9242998, 35)
Show SMILES CNC(=O)c1c(oc2cc(N(C)S(C)(=O)=O)c(cc12)-c1ccc2OCn3c(cc4c(F)cccc34)-c2n1)-c1ccc(nc1)C(F)(F)F
Show InChI InChI=1S/C32H23F4N5O5S/c1-37-31(42)28-19-11-18(21-8-9-25-29(39-21)24-12-17-20(33)5-4-6-22(17)41(24)15-45-25)23(40(2)47(3,43)44)13-26(19)46-30(28)16-7-10-27(38-14-16)32(34,35)36/h4-14H,15H2,1-3H3,(H,37,42)
PDB

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 3.10n/an/an/an/an/an/a



Merck Sharp & Dohme Corp.

US Patent


Assay Description
To initiate an assay, replicon cells were plated in the presence of a dilution series of test compound in the absence of G418. Typically, the assays ...


US Patent US9242998 (2016)


BindingDB Entry DOI: 10.7270/Q2SX6C2S
More data for this
Ligand-Target Pair
NS3 serine protease (NS3)


(Hepatitis C Virus (Virus))
BDBM204556
PNG
(US9242998, 36)
Show SMILES CNC(=O)c1c(oc2cc(N(C)S(C)(=O)=O)c(cc12)-c1ccc2OCn3c(cc4c(F)cccc34)-c2n1)-n1ccnc1
Show InChI InChI=1S/C29H23FN6O5S/c1-31-28(37)26-18-11-17(22(34(2)42(3,38)39)13-25(18)41-29(26)35-10-9-32-14-35)20-7-8-24-27(33-20)23-12-16-19(30)5-4-6-21(16)36(23)15-40-24/h4-14H,15H2,1-3H3,(H,31,37)
PDB

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 20n/an/an/an/an/an/a



Merck Sharp & Dohme Corp.

US Patent


Assay Description
To initiate an assay, replicon cells were plated in the presence of a dilution series of test compound in the absence of G418. Typically, the assays ...


US Patent US9242998 (2016)


BindingDB Entry DOI: 10.7270/Q2SX6C2S
More data for this
Ligand-Target Pair
NS3 serine protease (NS3)


(Hepatitis C Virus (Virus))
BDBM204557
PNG
(US9242998, 37)
Show SMILES CNC(=O)c1c(oc2cc(N(C)S(C)(=O)=O)c(cc12)-c1ccc2OCn3c(cc4c(F)cccc34)-c2n1)-n1ccccc1=O
Show InChI InChI=1S/C31H24FN5O6S/c1-33-30(39)28-19-13-18(23(35(2)44(3,40)41)15-26(19)43-31(28)36-12-5-4-9-27(36)38)21-10-11-25-29(34-21)24-14-17-20(32)7-6-8-22(17)37(24)16-42-25/h4-15H,16H2,1-3H3,(H,33,39)
PDB

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 3n/an/an/an/an/an/a



Merck Sharp & Dohme Corp.

US Patent


Assay Description
To initiate an assay, replicon cells were plated in the presence of a dilution series of test compound in the absence of G418. Typically, the assays ...


US Patent US9242998 (2016)


BindingDB Entry DOI: 10.7270/Q2SX6C2S
More data for this
Ligand-Target Pair
NS3 serine protease (NS3)


(Hepatitis C Virus (Virus))
BDBM204558
PNG
(US9242998, 38)
Show SMILES CNC(=O)c1c(oc2cc(N(C)S(C)(=O)=O)c(cc12)-c1ccc2OCn3c(cc4c(F)cccc34)-c2n1)-n1ccc(C)cc1=O
Show InChI InChI=1S/C32H26FN5O6S/c1-17-10-11-37(28(39)12-17)32-29(31(40)34-2)20-13-19(24(15-27(20)44-32)36(3)45(4,41)42)22-8-9-26-30(35-22)25-14-18-21(33)6-5-7-23(18)38(25)16-43-26/h5-15H,16H2,1-4H3,(H,34,40)
PDB

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 2.70n/an/an/an/an/an/a



Merck Sharp & Dohme Corp.

US Patent


Assay Description
To initiate an assay, replicon cells were plated in the presence of a dilution series of test compound in the absence of G418. Typically, the assays ...


US Patent US9242998 (2016)


BindingDB Entry DOI: 10.7270/Q2SX6C2S
More data for this
Ligand-Target Pair
NS3 serine protease (NS3)


(Hepatitis C Virus (Virus))
BDBM204559
PNG
(US9242998, 39)
Show SMILES CNC(=O)c1c(oc2cc(N(C)S(C)(=O)=O)c(cc12)-c1ccc2OCn3c(cc4c(F)cccc34)-c2n1)-n1cc(C)cn1
Show InChI InChI=1S/C30H25FN6O5S/c1-16-13-33-37(14-16)30-27(29(38)32-2)19-10-18(23(12-26(19)42-30)35(3)43(4,39)40)21-8-9-25-28(34-21)24-11-17-20(31)6-5-7-22(17)36(24)15-41-25/h5-14H,15H2,1-4H3,(H,32,38)
PDB

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 67n/an/an/an/an/an/a



Merck Sharp & Dohme Corp.

US Patent


Assay Description
To initiate an assay, replicon cells were plated in the presence of a dilution series of test compound in the absence of G418. Typically, the assays ...


US Patent US9242998 (2016)


BindingDB Entry DOI: 10.7270/Q2SX6C2S
More data for this
Ligand-Target Pair
NS3 serine protease (NS3)


(Hepatitis C Virus (Virus))
BDBM204560
PNG
(US9242998, 40)
Show SMILES CNC(=O)c1c(oc2cc(N(C)S(C)(=O)=O)c(cc12)-c1ccc2OCn3c(cc4c(F)cccc34)-c2n1)-n1cccn1
Show InChI InChI=1S/C29H23FN6O5S/c1-31-28(37)26-18-12-17(22(34(2)42(3,38)39)14-25(18)41-29(26)36-11-5-10-32-36)20-8-9-24-27(33-20)23-13-16-19(30)6-4-7-21(16)35(23)15-40-24/h4-14H,15H2,1-3H3,(H,31,37)
PDB

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 22n/an/an/an/an/an/a



Merck Sharp & Dohme Corp.

US Patent


Assay Description
To initiate an assay, replicon cells were plated in the presence of a dilution series of test compound in the absence of G418. Typically, the assays ...


US Patent US9242998 (2016)


BindingDB Entry DOI: 10.7270/Q2SX6C2S
More data for this
Ligand-Target Pair
NS3 serine protease (NS3)


(Hepatitis C Virus (Virus))
BDBM204561
PNG
(US9242998, 41)
Show SMILES CNC(=O)c1c(oc2cc(N(C)S(C)(=O)=O)c(cc12)-c1ccc2OCn3c(cc4c(F)cccc34)-c2n1)-n1cnc(C)n1
Show InChI InChI=1S/C29H24FN7O5S/c1-15-32-13-37(34-15)29-26(28(38)31-2)18-10-17(22(12-25(18)42-29)35(3)43(4,39)40)20-8-9-24-27(33-20)23-11-16-19(30)6-5-7-21(16)36(23)14-41-24/h5-13H,14H2,1-4H3,(H,31,38)
PDB

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 22n/an/an/an/an/an/a



Merck Sharp & Dohme Corp.

US Patent


Assay Description
To initiate an assay, replicon cells were plated in the presence of a dilution series of test compound in the absence of G418. Typically, the assays ...


US Patent US9242998 (2016)


BindingDB Entry DOI: 10.7270/Q2SX6C2S
More data for this
Ligand-Target Pair
NS3 serine protease (NS3)


(Hepatitis C Virus (Virus))
BDBM204562
PNG
(US9242998, 42)
Show SMILES CNC(=O)c1c(oc2cc(N(C)S(C)(=O)=O)c(cc12)-c1ccc2OCn3c(cc4c(F)cccc34)-c2n1)N1CCOCC1
Show InChI InChI=1S/C30H28FN5O6S/c1-32-29(37)27-19-13-18(23(34(2)43(3,38)39)15-26(19)42-30(27)35-9-11-40-12-10-35)21-7-8-25-28(33-21)24-14-17-20(31)5-4-6-22(17)36(24)16-41-25/h4-8,13-15H,9-12,16H2,1-3H3,(H,32,37)
PDB

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 35n/an/an/an/an/an/a



Merck Sharp & Dohme Corp.

US Patent


Assay Description
To initiate an assay, replicon cells were plated in the presence of a dilution series of test compound in the absence of G418. Typically, the assays ...


US Patent US9242998 (2016)


BindingDB Entry DOI: 10.7270/Q2SX6C2S
More data for this
Ligand-Target Pair
NS3 serine protease (NS3)


(Hepatitis C Virus (Virus))
BDBM204563
PNG
(US9242998, 43)
Show SMILES CNC(=O)c1c(oc2cc(N(C)S(C)(=O)=O)c(cc12)-c1ccc2OCn3c(cc4c(F)cccc34)-c2n1)N1CCOC1=O
Show InChI InChI=1S/C29H24FN5O7S/c1-31-27(36)25-17-11-16(21(33(2)43(3,38)39)13-24(17)42-28(25)34-9-10-40-29(34)37)19-7-8-23-26(32-19)22-12-15-18(30)5-4-6-20(15)35(22)14-41-23/h4-8,11-13H,9-10,14H2,1-3H3,(H,31,36)
PDB

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 50n/an/an/an/an/an/a



Merck Sharp & Dohme Corp.

US Patent


Assay Description
To initiate an assay, replicon cells were plated in the presence of a dilution series of test compound in the absence of G418. Typically, the assays ...


US Patent US9242998 (2016)


BindingDB Entry DOI: 10.7270/Q2SX6C2S
More data for this
Ligand-Target Pair
NS3 serine protease (NS3)


(Hepatitis C Virus (Virus))
BDBM204564
PNG
(US9242998, 44)
Show SMILES CNC(=O)c1c(oc2cc(N(C)S(C)(=O)=O)c(cc12)-c1ccc2OCn3c(cc4ccccc34)-c2n1)C1=CCCC1
Show InChI InChI=1S/C31H28N4O5S/c1-32-31(36)28-21-15-20(24(34(2)41(3,37)38)16-27(21)40-30(28)18-8-4-5-9-18)22-12-13-26-29(33-22)25-14-19-10-6-7-11-23(19)35(25)17-39-26/h6-8,10-16H,4-5,9,17H2,1-3H3,(H,32,36)
PDB

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 8.30n/an/an/an/an/an/a



Merck Sharp & Dohme Corp.

US Patent


Assay Description
To initiate an assay, replicon cells were plated in the presence of a dilution series of test compound in the absence of G418. Typically, the assays ...


US Patent US9242998 (2016)


BindingDB Entry DOI: 10.7270/Q2SX6C2S
More data for this
Ligand-Target Pair
NS3 serine protease (NS3)


(Hepatitis C Virus (Virus))
BDBM204565
PNG
(US9242998, 45)
Show SMILES CNC(=O)c1c(oc2cc(N(C)S(C)(=O)=O)c(cc12)-c1ccc2OCn3c(cc4c(F)cccc34)-c2n1)C1=CCCC1
Show InChI InChI=1S/C31H27FN4O5S/c1-33-31(37)28-20-13-19(24(35(2)42(3,38)39)15-27(20)41-30(28)17-7-4-5-8-17)22-11-12-26-29(34-22)25-14-18-21(32)9-6-10-23(18)36(25)16-40-26/h6-7,9-15H,4-5,8,16H2,1-3H3,(H,33,37)
PDB

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 6.40n/an/an/an/an/an/a



Merck Sharp & Dohme Corp.

US Patent


Assay Description
To initiate an assay, replicon cells were plated in the presence of a dilution series of test compound in the absence of G418. Typically, the assays ...


US Patent US9242998 (2016)


BindingDB Entry DOI: 10.7270/Q2SX6C2S
More data for this
Ligand-Target Pair
NS3 serine protease (NS3)


(Hepatitis C Virus (Virus))
BDBM204566
PNG
(US9242998, 46)
Show SMILES CNC(=O)c1c(oc2cc(N(C)S(C)(=O)=O)c(cc12)-c1ncc2OCn3c(cc4ccccc34)-c2n1)C1=CCCC1
Show InChI InChI=1S/C30H27N5O5S/c1-31-30(36)26-20-13-19(22(34(2)41(3,37)38)14-24(20)40-28(26)17-8-4-5-9-17)29-32-15-25-27(33-29)23-12-18-10-6-7-11-21(18)35(23)16-39-25/h6-8,10-15H,4-5,9,16H2,1-3H3,(H,31,36)
PDB

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 13n/an/an/an/an/an/a



Merck Sharp & Dohme Corp.

US Patent


Assay Description
To initiate an assay, replicon cells were plated in the presence of a dilution series of test compound in the absence of G418. Typically, the assays ...


US Patent US9242998 (2016)


BindingDB Entry DOI: 10.7270/Q2SX6C2S
More data for this
Ligand-Target Pair
NS3 serine protease (NS3)


(Hepatitis C Virus (Virus))
BDBM204567
PNG
(US9242998, 47)
Show SMILES CNC(=O)c1c(oc2cc(N(C)S(C)(=O)=O)c(cc12)-c1ncc2OCn3c(cc4c(F)cccc34)-c2n1)C1=CCCC1
Show InChI InChI=1S/C30H26FN5O5S/c1-32-30(37)26-19-11-18(22(35(2)42(3,38)39)13-24(19)41-28(26)16-7-4-5-8-16)29-33-14-25-27(34-29)23-12-17-20(31)9-6-10-21(17)36(23)15-40-25/h6-7,9-14H,4-5,8,15H2,1-3H3,(H,32,37)
PDB

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 8.80n/an/an/an/an/an/a



Merck Sharp & Dohme Corp.

US Patent


Assay Description
To initiate an assay, replicon cells were plated in the presence of a dilution series of test compound in the absence of G418. Typically, the assays ...


US Patent US9242998 (2016)


BindingDB Entry DOI: 10.7270/Q2SX6C2S
More data for this
Ligand-Target Pair
NS3 serine protease (NS3)


(Hepatitis C Virus (Virus))
BDBM204568
PNG
(US9242998, 48)
Show SMILES CNC(=O)c1c(oc2cc(N(C)S(C)(=O)=O)c(cc12)-c1ccc2OCn3c(cc4c(F)cccc34)-c2n1)C12CC1CCC2
Show InChI InChI=1S/C32H29FN4O5S/c1-34-31(38)28-20-12-19(24(36(2)43(3,39)40)14-27(20)42-30(28)32-11-5-6-17(32)15-32)22-9-10-26-29(35-22)25-13-18-21(33)7-4-8-23(18)37(25)16-41-26/h4,7-10,12-14,17H,5-6,11,15-16H2,1-3H3,(H,34,38)
PDB

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 34n/an/an/an/an/an/a



Merck Sharp & Dohme Corp.

US Patent


Assay Description
To initiate an assay, replicon cells were plated in the presence of a dilution series of test compound in the absence of G418. Typically, the assays ...


US Patent US9242998 (2016)


BindingDB Entry DOI: 10.7270/Q2SX6C2S
More data for this
Ligand-Target Pair
Displayed 1 to 50 (of 368 total )  |  Next  |  Last  >>
Jump to: